LION GETS NEW AND UPGRADED LICENSES FOR SRS.LION bioscience AG (Nasdaq: LEON) has expanded its presence in the Italian life science market with new and upgraded licenses for SRS SRS, SRS-A see slow-reacting substance. , its industry-leading integration technology for biological data, as well as for its Expression Profiling Microarray technology is often used for gene expression profiling. It makes use of the sequence resources created by the genome sequencing projects and other sequencing efforts to answer the question, Solution for better microarray See micro array. microarray - A technique for performing many DNA experiments in parallel. Nothing to do with computers. analysis. Financial details were not disclosed. Chiron Vaccines, the world's fifth-largest vaccine company, has upgraded its basic licenses from LION to perpetual SRS licenses and LION's Expression Profiling Solution, a comprehensive microarray analysis and integration solution. The Siena-based Chiron had already signed a one-year license last year for basic SRS functionality and arraySCOUT(TM), a stand-alone tool for microarray analysis. "LION's solution to data integration has been chosen as our software platform for data management," said Dr. Antonello Covacci, Head of the Cellular Microbiology microbiology: see biology. microbiology Scientific study of microorganisms, a diverse group of simple life-forms including protozoans, algae, molds, bacteria, and viruses. and Bioinformatics Unit of Chiron Vaccines. "We think the SRS and Expression Profiling technology will be instrumental in improving our research efforts at Chiron Vaccines." Furthermore, LION has licensed SRS to Axxam S.r.l., a Milan-based biotechnology company, to serve as the central bioinformatics platform for their research efforts and further informatics Same as information technology and information systems. The term is more widely used in Europe. development. "SRS was the most practical choice for text-based querying of the sequence databases and will serve as our central point of data management," said Axxam's Head of Bioinformatics, Gyorgy Simon. "Several bioinformatics client and product support utilities and internal databases, to be developed in the near future, will be designed on the basis of the data access methods provided by SRS." "We are delighted to expand our presence in Italy's growing life science market with these two latest deals with Chiron and Axxam," said LION bioscience vice president for Global Sales Jason Theodosiou. "These agreements further illustrate LION's ability to deliver comprehensive solutions to different customer types with varying needs, while allowing for effortless ef·fort·less adj. Calling for, requiring, or showing little or no effort. See Synonyms at easy. ef  fort·less·ly adv. upgrade potential to suit the evolving needs of each customer. We are especially pleased by Chiron's choice of a more comprehensive suite of LION technology." Chiron Vaccines will use LION's Expression Profiling Solution and SRS Evolution technology for better integration of genetic data related to bacterial and virus research in order to develop better vaccine candidates more quickly and easily. The Expression Profiling Solution combines tools for the statistical analysis of microarray technology with the integration capability of SRS to link public and private databases to microarray analysis data. This comprehensive approach to integration is a key benefit for researchers. About SRS SRS is a proven, scalable and robust data integration platform that provides fast access to diverse life science data - genetic, protein, cellular, molecular and clinical - from public and proprietary sources, regardless of data format. SRS is used in more than 280 commercial and academic sites delivering genomic genomic pertaining to a genome. genomic clone see clone. genomic DNA the DNA sequences making up the genome of an individual. genomic library see gene bank. data daily to thousands of users around the globe. SRS is the clear market leader for bioinformatics data integration, providing global bioinformatics platforms for pharmaceutical companies such as Eli Lilly Eli Lilly can refer to:
About Chiron Vaccine S.r.l Chiron Vaccines, the fifth largest vaccine business in the world, currently offers more than 30 novel and conventional vaccines for adults and children. Chiron Vaccines' mission is to bring to the market, through innovation and creativity, biological solutions needed for the prevention and treatment of infectious diseases infectious diseases: see communicable diseases. . Every second, 25 people across more than 70 countries of the world are vaccinated with a Chiron vaccine. About Axxam S.r.l. Axxam is a privately held biotechnology company founded in May 2001. Axxam has a competitive edge in the fields of genomics and bioinformatics, assay development, screening and lead profiling. Axxam's technological platforms, which support the entire Genes-to-Leads process, consist of bioinformatics, molecular and cell biology Cell biology The study of the activities, functions, properties, and structures of cells. Cells were discovered in the middle of the seventeenth century after the microscope was invented. , signal detection systems, liquid handling technologies and screening. Axxam is active in the field of life sciences (pharmaceutical, diagnostic and agri-chemical sectors). Axxam has a network of industrial collaborations, including Bayer AG Bayer AG German chemical and pharmaceutical company. Founded in 1863 by Friedrich Bayer (1825–1880), it now operates plants in more than 30 countries. Bayer has originated scores of pharmaceuticals, chemicals, and synthetic materials; it was the first developer and , Chiesi Pharmaceuticals SpA, NicOx SA, Primm srl, Gruenethal GmbH and Newron Pharmaceuticals SpA. About LION bioscience AG LION bioscience (ISIN Isin (ĭs`ĭn), capital of an ancient Semitic kingdom of N Babylonia. The city became important after the third dynasty of Ur fell to the Elamites and the Amorites (c.2025 B.C.). The phase from c.2025–c.1763 B.C. : DE0005043509, Reuters: LIOG LIOG Lie in Our Graves (song) , Bloomberg: LIO, Nasdaq: LEON) provides proven information and knowledge management solutions to significantly improve life science R&D performance and productivity. LION's performance software solutions developed by its scientific and IT experts enable researchers to simultaneously compile and analyze data across various phases of the R&D process. Research time and costs are reduced, as scientists are able to identify and focus on the most promising drug candidates earlier. LION sets the standard for integration solutions with more than 280 corporate and academic customers globally including AstraZeneca, Aventis, Bayer, Boehringer Ingelheim, Celera, DuPont, Eli Lilly, GlaxoSmithKline, IBM (International Business Machines Corporation, Armonk, NY, www.ibm.com) The world's largest computer company. IBM's product lines include the S/390 mainframes (zSeries), AS/400 midrange business systems (iSeries), RS/6000 workstations and servers (pSeries), Intel-based servers (xSeries) , Incyte, Johnson & Johnson, Merck Inc., Nestle, Novartis, Schering AG and Sumitomo Pharmaceuticals. For more information, visit http://www.lionbioscience.com or call 617/245-5433. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion